The study by Kojima et al., has shown that the miRNAs miR-I and miR-I33a targets PNP gene which potentially functions as an oncogene favoring oncogenesis and progression of prostate cancer (PCa) and hence, suggests PNP inhibition as a novel strategy for better treatment of PCa [38]. The gene discussed is PNP; the disease is prostate carcinoma.